BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1079 related articles for article (PubMed ID: 18670822)

  • 21. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
    Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
    Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
    Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
    Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.
    Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR
    Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer.
    Nakashima S; Natsugoe S; Matsumoto M; Miyazono F; Nakajo A; Uchikura K; Tokuda K; Ishigami S; Baba M; Takao S; Aikou T
    Surgery; 2003 Feb; 133(2):162-9. PubMed ID: 12605177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-time PCR (TaqMan PCR) quantification of carcinoembryonic antigen (CEA) mRNA in the peripheral blood of colorectal cancer patients.
    Miura M; Ichikawa Y; Tanaka K; Kamiyama M; Hamaguchi Y; Ishikawa T; Yamaguchi S; Togo S; Ike H; Ooki S; Shimada H
    Anticancer Res; 2003; 23(2B):1271-6. PubMed ID: 12820382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients.
    Ferroni P; Roselli M; Spila A; D'Alessandro R; Portarena I; Mariotti S; Palmirotta R; Buonomo O; Petrella G; Guadagni F
    Cancer; 2010 Jun; 116(12):2913-21. PubMed ID: 20336782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.
    Shen C; Hu L; Xia L; Li Y
    Clin Biochem; 2009 Feb; 42(3):194-200. PubMed ID: 19022237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples.
    Wharton RQ; Jonas SK; Glover C; Khan ZA; Klokouzas A; Quinn H; Henry M; Allen-Mersh TG
    Clin Cancer Res; 1999 Dec; 5(12):4158-63. PubMed ID: 10632355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
    Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
    Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinoembryonic antigen messenger RNA expression using nested reverse transcription-PCR in the peripheral blood during follow-up period of patients who underwent curative surgery for biliary-pancreatic cancer: longitudinal analyses.
    Mataki Y; Takao S; Maemura K; Mori S; Shinchi H; Natsugoe S; Aikou T
    Clin Cancer Res; 2004 Jun; 10(11):3807-14. PubMed ID: 15173089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of cytokeratin20 mRNA in peripheral blood from colonic cancer patients by fluorescence quantitative polymerase chain reaction].
    Wang ZC; Wang C; Zeng QG
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):600-3. PubMed ID: 18210880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular detection of disseminated cancer cells in the peripheral blood of patients with gastric cancer.
    Nishida S; Kitamura K; Ichikawa D; Koike H; Tani N; Yamagishi H
    Anticancer Res; 2000; 20(3B):2155-9. PubMed ID: 10928170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer.
    Tani N; Ichikawa D; Ikoma D; Tomita H; Sai S; Ikoma H; Okamoto K; Ochiai T; Ueda Y; Otsuji E; Yamagishi H; Miura N; Shiota G
    Anticancer Res; 2007; 27(2):1207-12. PubMed ID: 17465264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analysis of tumor markers and evaluation of their predictive value in patients with colorectal cancer.
    Liu ZP; Li LM; Liu XL; Zhang DX
    Onkologie; 2012; 35(3):108-13. PubMed ID: 22414974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
    Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
    Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble VCAM-1 and E-selectin in breast cancer: relationship with staging and with the detection of circulating cancer cells.
    Silva HC; Garcao F; Coutinho EC; De Oliveira CF; Regateiro FJ
    Neoplasma; 2006; 53(6):538-43. PubMed ID: 17167725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer.
    Lledó SM; Garcia-Granero E; Dasí F; Ripoli R; García SA; Cervantes A; Aliño SF
    Colorectal Dis; 2004 Jul; 6(4):236-42. PubMed ID: 15206965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of survivin mRNA in peritoneal lavage fluid from patients with gastric carcinoma.
    Wang ZN; Xu HM; Jiang L; Zhou X; Lu C; Zhang X
    Chin Med J (Engl); 2004 Aug; 117(8):1210-7. PubMed ID: 15361297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease.
    Gradilone A; Gazzaniga P; Silvestri I; Gandini O; Trasatti L; Lauro S; Frati L; Aglianò AM
    Oncol Rep; 2003; 10(1):217-22. PubMed ID: 12469172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.